Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Retrospective Analysis of Clinical Outcomes of Utilizing R-CHOP Plus Zanubrutinib for High-Risk Diffuse Large B Cell Lymphoma Patients with Extranodal Involvement or MYC/BCL2 Double Expression

Wanbin Fu, Jia Liu, Dan Xiao, Huanbin Zhao, Ting Wang, Jiong Hu, Jian Hou, Hua Zhong, Lan Xu

Blood (2023) 142 (Supplement 1): 6323.

https://doi.org/10.1182/blood-2023-182704

Published: 2023

Journal Articles

Optimization of Idarubicin and Cytarabine Induction Regimen with Homoharringtonine for Newly Diagnosed AML Based on the Peripheral Blast Clearance Rate: First Result of the Multicenter, Randomized, Phase 3 Trial (RJ-AML 2016)

Yunxiang Zhang, Qiusheng Chen, Xiangqin Weng, Yang Shen, Wen Wu, Jiong Hu, Jie Hao, Ligen Liu, Junmin Li

Blood (2023) 142 (Supplement 1): 829.

https://doi.org/10.1182/blood-2023-179311

Published: 2023

Journal Articles

Clinical Characteristics, Genetic Profile and Prognosis of Adult Acute Myeloid Leukemia with NUP98 Rearrangement

Hongming Zhu, Yubing Zhao, Wenyan Cheng, Xinjie Chen, Yunxiang Zhang, Jiong Hu, Junmin Li, Yang Shen

Blood (2023) 142 (Supplement 1): 2867.

https://doi.org/10.1182/blood-2023-178329

Published: 2023

Journal Articles

Idarubicin Plus Azacitidine + Venetoclax As Induction Therapy Achieved High Remission in Elderly Fit- Acute Myeloid Leukemia Patients: Preliminary Results of a Phase II Study

Xinjie Chen, Diyaer Abuduaini, Hongming Zhu, Jun Long, Jiong Hu, Wen Wu, Yang Shen

Blood (2023) 142 (Supplement 1): 1527.

https://doi.org/10.1182/blood-2023-180049

Published: 2023

Journal Articles

Arsenic Trioxide Combine with G-CSF Triggers Distinct TP53 Mutations Acute Myeloid Leukemia Cells Ferroptosis through TP53-SLC7A11-GPX4 Pathway

Gelan Zhu, Wanbin Fu, Lan Xu, Yiwei Zhang, Jiong Hu, Jian Hou, Hua Zhong

Blood (2023) 142 (Supplement 1): 5989.

https://doi.org/10.1182/blood-2023-180676

Published: 2023

Journal Articles

ENO1 Contributes to Cell Proliferation and Invasion in Burkitt's Lymphoma

Jinsong Yan, Haina Wang, Shanshan Zhang, Jiong Hu

Blood (2022) 140 (Supplement 1): 11521.

https://doi.org/10.1182/blood-2022-169190

Published: 2022

Journal Articles

Fludarabine, Busulfan and Melphalan Based Conditioning Reduced Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myeloid Malignancies: A Multicenter Retrospective Analysis

Jieling Jiang, Sanbin Wang, Xiaojin WU, Xiao Lin Yin, Xiaofan Li, Dong Wu, Quanyi Lu, Kourong Miao, Houcai Wang, Jiong Hu

Blood (2022) 140 (Supplement 1): 10465–10466.

https://doi.org/10.1182/blood-2022-166286

Published: 2022

Journal Articles

Targeting HDAC3 to Overcome the Resistance to ATRA or Arsenic in Acute Promyelocytic Leukemia through Ubiquitination and Degradation of PML-RARα

Bo Dai, Feng Wang, Ying Wang, Jiayan Zhu, Yunxuan Li, Tingting Zhang, Luyao Zhao, Li-Ling Wang, Wenhui GAO, Junmin Li, Aibin Liang, Hong-hu Zhu, Ke Li, Jiong Hu

Blood (2022) 140 (Supplement 1): 5924–5925.

https://doi.org/10.1182/blood-2022-156735

Published: 2022

Journal Articles

EP300-ZNF384 Rearrangement Drive B-Cell Acute Lymphoblastic Leukemia Development By Activating IL3-IL3RA Signaling

Jinsong Yan, Zhijie Hou, Yifei Ren, Jiong Hu

Blood (2022) 140 (Supplement 1): 11508.

https://doi.org/10.1182/blood-2022-168535

Published: 2022

Journal Articles

Protective Effects on Melphalan-Induced Mouse Intestinal Injuries Treated By Human Umbilical Cord-Derived Mesenchymal Stem Cells

Jinsong Yan, Yifei Ren, Zhijie Hou, Jiong Hu

Blood (2022) 140 (Supplement 1): 12663–12664.

https://doi.org/10.1182/blood-2022-169019

Published: 2022

Journal Articles

Post-Transplantation Cyclophosphamide Combined with Tacrolimus and Low-Dose Post-Engraftment Anti-Thymoglobulin As Gvhd Prophylaxis for Patients Undergoing Peripheral Blood Stem Cell Transplantation from Haplo Donors: A Single Center Analysis

Jiong Hu, Wenhui GAO, Ming Chen, Li-Ling Wang, Ling Wang, Raynier Devillier, Jie-Ling Jiang, Didier Blaise

Blood (2022) 140 (Supplement 1): 12878–12879.

https://doi.org/10.1182/blood-2022-168484

Published: 2022

Journal Articles

A Phase IV, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) As a Myeloablative Conditioning Regimen in Chinese Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Fengrong Wang, Zhen Cai, Dehui Zou, Wenming Chen, Yongping Song, Chengcheng Fu, Jiong Hu, Ting Yang, Xinchuan Chen, Jinsong Yan, Kaiyan Liu

Blood (2022) 140 (Supplement 1): 4845–4847.

https://doi.org/10.1182/blood-2022-163171

Published: 2022

Journal Articles

Autologous Versus Haploidentical Stem Cell Transplantation in Adult Patients with Intermediate Risk Actue Myelogenous Leukemia in First Complete Remission and Undetectable Minimal Residual Disease: A Global Preliminary Analysis of Chinese Data

Jia Chen, Yiyang Ding, Xi Zhang, Erlie Jiang, Lin Liu, He Huang, Jiong Hu, Jishi Wang, Yanming Zhang, Myriam Labopin, Irma Khvedelidze, Emmanuelle Polge, Arnon Nagler, Mohamad Mohty, Depei Wu, Norbert Claude Gorin, Sr.

Blood (2022) 140 (Supplement 1): 12952–12953.

https://doi.org/10.1182/blood-2022-165709

Published: 2022

Journal Articles

G-CSF Upregulates the Expression of Aquaporin-9 through C/EBP-Beta to Enhance the Cytotoxic Activity of Arsenic Trioxide to Acute Myeloid Leukemia Cells

Wanbin Fu, Lan Xu, Jia Liu, Xiaofeng Han, Junying Wang, Xinpeng Wang, Huanbin Zhao, Jian Hou, Jiong Hu, Hua Zhong

Blood (2021) 138 (Supplement 1): 4338.

https://doi.org/10.1182/blood-2021-149973

Published: 2021

Journal Articles

FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD + acute myeloid leukemia

Blood (2020) 135 (17): 1472–1483.

https://doi.org/10.1182/blood.2019003538

Published: 2020

Includes: Supplemental data

Journal Articles

Role of HDAC8 Upregulation in Resistance of FLT3-ITD AML Stem Cells to FLT3 Inhibitors

Jun Long, Mingyuan Jia, Weiyue Fang, Xinjie Chen, Zhongyu Wang, Lili Mu, Rufang Xiang, Jun-Min LI, MD PhD, Dengli Hong, PhD, Aibin Liang, MD PhD, Jiong Hu, MD

Blood (2019) 134 (Supplement_1): 1268.

https://doi.org/10.1182/blood-2019-128394

Published: 2019

Journal Articles

The simpler, the better: oral arsenic for acute promyelocytic leukemia

Hong-Hu Zhu, Jiong Hu, Francesco Lo-Coco, Jie Jin

Blood (2019) 134 (7): 597–605.

https://doi.org/10.1182/blood.2019000760

Published: 2019

Includes: Supplemental data

Journal Articles

Low Dose Anti-Thymocyte Globulin Plus Low Dose Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in Haploidentical Peripheral Blood Stem Cell Transplantation for Patients with Hematologic Malignancies: A Prospective, Phase II Study

Jun Yang, Jiang Jieling, Yu CAI, MD, Su Li, Liping Wan, Jun Zhu, Huixia Liu, Shan Shao, Haitao Bai, Chun Wang, Jiong Hu, MD, Xianmin Song

Blood (2018) 132 (Supplement 1): 4575.

https://doi.org/10.1182/blood-2018-99-110727

Published: 2018

Journal Articles

Identification of Individualized Minimal Residual Disease in Acute Myeloid Leukemia By Flow Cytometry and Its Application of Prognostic Significance

Jing-Ni Sui, Qiu-Sheng Chen, Yun-Xiang Zhang, Yan Sheng, Jing Wu, Jun-Min Li, Jiong Hu, MD, Xiang-Qin Weng, Bing Chen, MD PhD

Blood (2018) 132 (Supplement 1): 1522.

https://doi.org/10.1182/blood-2018-99-112367

Published: 2018

Journal Articles

PML Mutation in PML-Rarα Alters PML Nuclear Body Organization and Induces ATRA Resistance in Acute Promyelocytic Leukemia

Hong-Hu Zhu, MD, Congying Wu, Yujie Sun, Jiong Hu, MD

Blood (2018) 132 (Supplement 1): 3923.

https://doi.org/10.1182/blood-2018-99-118310

Published: 2018

NARROW

Retrospective Analysis of Clinical Outcomes of Utilizing R-CHOP Plus Zanubrutinib for High-Risk Diffuse Large B Cell Lymphoma Patients with Extranodal Involvement or MYC/BCL2 Double Expression

Optimization of Idarubicin and Cytarabine Induction Regimen with Homoharringtonine for Newly Diagnosed AML Based on the Peripheral Blast Clearance Rate: First Result of the Multicenter, Randomized, Phase 3 Trial (RJ-AML 2016)

Clinical Characteristics, Genetic Profile and Prognosis of Adult Acute Myeloid Leukemia with NUP98 Rearrangement

Idarubicin Plus Azacitidine + Venetoclax As Induction Therapy Achieved High Remission in Elderly Fit- Acute Myeloid Leukemia Patients: Preliminary Results of a Phase II Study

Arsenic Trioxide Combine with G-CSF Triggers Distinct TP53 Mutations Acute Myeloid Leukemia Cells Ferroptosis through TP53-SLC7A11-GPX4 Pathway

ENO1 Contributes to Cell Proliferation and Invasion in Burkitt's Lymphoma

Fludarabine, Busulfan and Melphalan Based Conditioning Reduced Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myeloid Malignancies: A Multicenter Retrospective Analysis

Targeting HDAC3 to Overcome the Resistance to ATRA or Arsenic in Acute Promyelocytic Leukemia through Ubiquitination and Degradation of PML-RARα

EP300-ZNF384 Rearrangement Drive B-Cell Acute Lymphoblastic Leukemia Development By Activating IL3-IL3RA Signaling

Protective Effects on Melphalan-Induced Mouse Intestinal Injuries Treated By Human Umbilical Cord-Derived Mesenchymal Stem Cells

Post-Transplantation Cyclophosphamide Combined with Tacrolimus and Low-Dose Post-Engraftment Anti-Thymoglobulin As Gvhd Prophylaxis for Patients Undergoing Peripheral Blood Stem Cell Transplantation from Haplo Donors: A Single Center Analysis

A Phase IV, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) As a Myeloablative Conditioning Regimen in Chinese Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Autologous Versus Haploidentical Stem Cell Transplantation in Adult Patients with Intermediate Risk Actue Myelogenous Leukemia in First Complete Remission and Undetectable Minimal Residual Disease: A Global Preliminary Analysis of Chinese Data

G-CSF Upregulates the Expression of Aquaporin-9 through C/EBP-Beta to Enhance the Cytotoxic Activity of Arsenic Trioxide to Acute Myeloid Leukemia Cells

FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD + acute myeloid leukemia

Role of HDAC8 Upregulation in Resistance of FLT3-ITD AML Stem Cells to FLT3 Inhibitors

The simpler, the better: oral arsenic for acute promyelocytic leukemia

Low Dose Anti-Thymocyte Globulin Plus Low Dose Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in Haploidentical Peripheral Blood Stem Cell Transplantation for Patients with Hematologic Malignancies: A Prospective, Phase II Study

Identification of Individualized Minimal Residual Disease in Acute Myeloid Leukemia By Flow Cytometry and Its Application of Prognostic Significance

PML Mutation in PML-Rarα Alters PML Nuclear Body Organization and Induces ATRA Resistance in Acute Promyelocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only